Jordan Pomeroy, MD, PhD

Start Year
2016

Education and Training

College/University
University of Oregon

Medical School
Keck School of Medicine of the University of Southern California

Residency
Duke

Career and research goals

I am a physician-scientist with a passion for developing novel, tissue-engineered models of cardiovascular disease. As part of the Duke Clinician Investigator Pathway (CIP), I have spent the past three years becoming an expert in cardiac tissue engineering as a postdoc in the lab of Nenad Bursac in the Duke Department of Biomedical Engineering. Over the next two years of clinical cardiology fellowship I will foster unique, patient-centered questions to deploy in the lab. Upon completion of fellowship in 2021, I will seek to establish my own lab with the goal to become a fully-funded, independent investigator at a major academic medical research center. I hope to be a leader in cardiac tissue engineering developing new tools for discovery biology and cardiac disease modeling.

Honors, awards and distinctions

  • NIH Loan Repayment Program (NHLBI): 2018-2020
  • NIH T32 in Cardiovascular Diseases: 2016-2019
  • Duke OPSD Technician Support Award: 2019
  • John J Pohanka Family Foundation Award: 2016
  • Lefkowitz Society Inductee: 2014
  • Alpha Omega Alpha: 2014
  • Eagle Scout: 1997

About the Duke program

What are the strengths of the Duke program?
Duke is an amazing place for multiple reasons. First and foremost, Duke is among a handful of world class academic medical research institutions that are located in a region with enormous quality of life. Living here is easy and enjoyable. Duke Cardiology is one of the principal divisions driving the academic mission whether your pursuit is founded by clinical or basic research questions. The ability to rapidly deploy patient-centered ideas in a highly collaborative environment is outstanding. If you come for the research, your bonus will be the tremendous clinical training provided in a high-volume, quaternary hospital system. Duke was, and still is, my #1 choice for cardiology fellowship.

About me

I am husband to Summer and father of two beautiful daughters, Parker Rose and Pepper (dog). My wife and I love the Triangle with its vast outdoor, cultural and social opportunities. Summer coaches girls lacrosse with Cary Academy HS and the Carolina Fever club team. I love to hike, paddleboard and surf...the OBX is fantastic!

Publications

Pomeroy, Jordan E., Hung X. Nguyen, Brenton D. Hoffman, and Nenad Bursac. “Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem Cells..” Theranostics 7, no. 14 (January 2017): 3539–58. https://doi.org/10.7150/thno.20593.

PMID
28912894
Full Text

Pomeroy, Jordan E., Shelley R. Hough, Kathryn C. Davidson, Alex M. Quaas, Jordan A. Rees, and Martin F. Pera. “Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts..” Stem Cells Translational Medicine 5, no. 7 (July 2016): 870–82. https://doi.org/10.5966/sctm.2015-0250.

PMID
27160704
Full Text

Hasegawa, Kouichi, Peilin Zhang, Zong Wei, Jordan E. Pomeroy, Wange Lu, and Martin F. Pera. “Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion..” Stem Cells (Dayton, Ohio) 28, no. 8 (August 2010): 1338–48. https://doi.org/10.1002/stem.466.

PMID
20572011
Full Text

Hasegawa, Kouichi, Jordan E. Pomeroy, and Martin F. Pera. “Current technology for the derivation of pluripotent stem cell lines from human embryos..” Cell Stem Cell 6, no. 6 (June 2010): 521–31. https://doi.org/10.1016/j.stem.2010.05.010.

PMID
20569689
Full Text

Schwarz, David A., Molly M. Allen, Robert E. Petroski, Jordan E. Pomeroy, Christopher E. Heise, Monica S. Mistry, Julie V. Selkirk, et al. “Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 function..” Molecular and Cellular Endocrinology 259, no. 1–2 (October 2006): 1–9. https://doi.org/10.1016/j.mce.2006.07.003.

PMID
16987592
Full Text

Petroski, Robert E., Jordan E. Pomeroy, Ronnie Das, Heath Bowman, Weidong Yang, Adele P. Chen, and Alan C. Foster. “Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors..” The Journal of Pharmacology and Experimental Therapeutics 317, no. 1 (April 2006): 369–77. https://doi.org/10.1124/jpet.105.096701.

PMID
16399882
Full Text

Selkirk, Julie V., Lisa M. Nottebaum, Alicia M. Vana, Gail M. Verge, Kenneth B. Mackay, Theodore H. Stiefel, Greg S. Naeve, et al. “Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus..” The European Journal of Neuroscience 21, no. 12 (June 2005): 3217–28. https://doi.org/10.1111/j.1460-9568.2005.04162.x.

PMID
16026460
Full Text

Amores, Angel, Tohru Suzuki, Yi-Lin Yan, Jordan Pomeroy, Amy Singer, Chris Amemiya, and John H. Postlethwait. “Developmental roles of pufferfish Hox clusters and genome evolution in ray-fin fish..” Genome Research 14, no. 1 (January 2004): 1–10. https://doi.org/10.1101/gr.1717804.

PMID
14707165
Full Text